Your browser doesn't support javascript.
loading
Acute mesenteric ischemia due to superior mesenteric artery thrombosis in a patient with protein S deficiency: A case report.
Luitel, Prajjwol; Paudel, Sujan; Shrestha, Aron; Gyawali, Prashant; Gaire, Roshan; Dev, Santosh.
Afiliación
  • Luitel P; Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Nepal.
  • Paudel S; Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Nepal.
  • Shrestha A; Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Nepal. Electronic address: aronshrestha2003@gmail.com.
  • Gyawali P; Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Nepal.
  • Gaire R; Department of Radiology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Nepal.
  • Dev S; Department of General Surgery, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Int J Surg Case Rep ; 122: 110080, 2024 Jul 29.
Article en En | MEDLINE | ID: mdl-39088974
ABSTRACT

INTRODUCTION:

Protein S deficiency resulting in mesenteric vein thrombosis has been reported in previous studies however those causing SMA thrombosis has been rarely reported. Multidisciplinary approach involving general surgeon, a vascular surgeon, an interventional radiologist, and an intensivist are crucial for management of SMA thrombosis. CASE PRESENTATION A 39-year-old non-smoker hypertensive female who was diagnosed with partially occlusive thrombus in the superior mesenteric artery via Contrast-enhanced computed tomography (CECT) re-presented after 5 days and CECT revealed a partially occlusive thrombus in the superior mesenteric artery and Protein S deficiency (free protein S15 %). She was managed by lysis of thrombus with streptokinase by interventional radiology team. The patient is on anticoagulants and without abdominal complaints on follow-up at 24 months.

DISCUSSION:

Computed tomography angiography should be done immediately in any patient suspected of AMI since delay in diagnosis accounts for high mortality rates of 30-70 %. The surgical treatment of the condition is well established and consists of revascularization and/or resection of nonviable bowel. Endovascular techniques have emerged as an alternative for occlusion of the SMA. Patients with protein C and/or S deficiency treated for AMI require lifelong anticoagulant/antiplatelet therapy to prevent relapse.

CONCLUSION:

Hereditary thrombophilia should be suspected in young people with unusual thrombotic presentations. Earlier diagnosis and aggressive antithrombotic therapy in individuals with hypercoagulable states can improve outcomes. Treatment involving a multidisciplinary approach improves outcomes.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Int J Surg Case Rep Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Int J Surg Case Rep Año: 2024 Tipo del documento: Article